Perfusion

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gant, V A
Right arrow Articles by Berrill, K
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gant, V A
Right arrow Articles by Berrill, K
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Perfusion, Vol. 13, No. 6, 437-446 (1998)
DOI: 10.1177/026765919801300607

A novel leucocyte-depleting filter for use in continuous venovenous haemofiltration: preliminary in vitro studies

V A Gant

Department of Infection, UMDS, London, v.gant{at}umds.ac.uk

J May

Department of Infection, UMDS, London

D F Treacher

Department of Intensive Care, St Thomas’ Hospital, London

K Morris

Pall Europe Limited, Portsmouth, Hants

K Berrill

Pall Europe Limited, Portsmouth, Hants

Multiple organ failure (MOF) secondary to circulatory shock, sepsis, or trauma was first described over 20 years ago. Despite much research effort and clinical trials of biological response modifiers, MOF continues to be the leading cause of death in both medical and surgical intensive care units (ICU). MOF is associated with widespread cellular and humoral systemic inflammatory responses which, in turn, are linked with inadequate tissue perfusion to vital organs and the inappropriate accumulation of activated neutrophils, resulting in microcirculatory injury. Much evidence suggests that such activated neutrophils cause vascular damage by adhering to the endothelium and releasing a variety of highly reactive and toxic moieties; these may subsequently produce endothelial injury and compromised organ function. We reasoned that a clinical device designed to remove such cells in a controlled fashion from the circulation of patients with MOF by means of using a continuous venovenous circuit might be beneficial. We report the leucocyte depletion performance of a novel filter medium as a first step towards the production of a clinical device, and show specific depletion of phagocytes relative to other formed elements in the blood.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
PerfusionHome page
D F Treacher, M Sabbato, K A Brown, and V Gant
The effects of leucodepletion in patients who develop the systemic inflammatory response syndrome following cardiopulmonary bypass
Perfusion, January 1, 2001; 16(1_suppl): 67 - 73.
[Abstract] [PDF]